Roswell Park Cancer Insitute — Buffalo, New York

Roswell Park Cancer Insitute is a clinical research site located in Buffalo, New York, United States 14203.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Roswell Park Cancer Insitute has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma.

Sponsors: CRISPR Therapeutics AG, ImmunityBio, Inc..

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Roswell Park Cancer Insitute?

Roswell Park Cancer Insitute has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Roswell Park Cancer Insitute conducted?

Roswell Park Cancer Insitute has 2 clinical trials on record, with 1 currently active. Their work covers B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma.

Is Roswell Park Cancer Insitute accredited by Crixeo Health?

Roswell Park Cancer Insitute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Roswell Park Cancer Insitute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.